Towards a neuroprotective gene therapy for Parkinson’s disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model11Published on the World Wide Web on 10 October 2000.
Top Cited Papers
- 1 December 2000
- journal article
- review article
- Published by Elsevier in Brain Research
- Vol. 886 (1-2) , 82-98
- https://doi.org/10.1016/s0006-8993(00)02915-2
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Lentiviral Vectors: Regulated Gene ExpressionMolecular Therapy, 2000
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Recombinant adeno-associated virus purification using novel methods improves infectious titer and yieldGene Therapy, 1999
- Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of ExpressionHuman Gene Therapy, 1999
- Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in BrainHuman Gene Therapy, 1998
- Neuron-Specific Transduction in the Rat Septohippocampal or Nigrostriatal Pathway by Recombinant Adeno-associated Virus VectorsExperimental Neurology, 1998
- PET studies of functional compensation in a primate model of Parkinsonʼs diseaseNeuroReport, 1997
- Immune responses to adenovirus vectors in the nervous systemTrends in Neurosciences, 1996
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991